Keytruda, Padcev combo for bladder cancer approved by European Commission
at seekingalpha.com (Wed, 21-Oct 11:52 AM)
RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)
at www.tipranks.com (Tue, 20-Oct 9:47 PM)
CDC confirms third measles-related death for 2026
at seekingalpha.com (Tue, 20-Oct 1:42 PM)
XLV touches a new high, hitting overbought territory
at seekingalpha.com (Tue, 20-Oct 1:11 PM)
Why Is Silence Therapeutics (SLN) Stock Up 125% Today?
at www.tipranks.com (Mon, 19-Oct 9:34 AM)
Goldman's defensive stocks with quality-growth characteristics
at seekingalpha.com (Sun, 18-Oct 11:04 AM)
Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39
at seekingalpha.com (Fri, 16-Oct 3:00 PM)
Moderna falls ahead of cancer vaccine data next week
at seekingalpha.com (Fri, 16-Oct 12:09 PM)
Merck Names Paul J. Diaz to Board Starting Nov. 1, 2026, Expanding Directors to 14
Market Chameleon (Tue, 13-Oct 7:12 AM)
MRK Breaks New Ground with Positive Phase 3 Results for mRNA Cancer Vaccine Combination in Melanoma
Market Chameleon (Wed, 19-Aug 11:08 AM)
Market Chameleon (Wed, 19-Aug 7:07 AM)
Merck Raises Full-Year Outlook After Robust Q2 Growth and Regulatory Wins Across Pipeline
Market Chameleon (Tue, 4-Aug 7:16 AM)
Market Chameleon (Thu, 30-Jul 7:14 AM)
